The present study reveals the possible mechanisms of sivelestat against oxidative stress-induced AKI, including decreasing the level of MDA and increasing the levels of SOD and GSH-Px, and shows the possible therapeutic potential of sivelestat for sepsis-related AKI. The gene discussed is SOD1; the disease is Sepsis.